about
Etiology and pathogenesis of uterine leiomyomas: a reviewIdentification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization.Insights from gene arrays on the development and growth regulation of uterine leiomyomataReduced dermatopontin expression is a molecular link between uterine leiomyomas and keloidsDisseminated peritoneal leiomyomatosis after laparoscopic supracervical hysterectomy with characteristic molecular cytogenetic findings of uterine leiomyoma.Whole exome sequencing in a random sample of North American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas.The genetic bases of uterine fibroids; a review.Molecular genetics of benign tumors.Progestins and uterine leiomyoma.Warner-Lambert/Parke-Davis Award lecture. Many tumors and many genes: genetics of uterine leiomyomataHMGI(Y) expression in human uterine leiomyomata. Involvement of another high-mobility group architectural factor in a benign neoplasmChromosomal abnormalities in leiomyosarcomas.Chromosomal aberrations in soft tissue tumors. Relevance to diagnosis, classification, and molecular mechanisms.Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.Recombinations of chromosomal bands 6p21 and 14q24 characterise pulmonary hamartomasMolecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathwayImmortalization of primary human smooth muscle cellsLong-term use of progestogens--effects on endometriosis, adenomyosis and myomas.Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.De novo 13q13.3-21.31 deletion involving RB1 gene in a patient with hemangioendothelioma of the liver.Uterine innervation in fibroids: a qualitative study.Microchimeric Cells, Sex Chromosome Aneuploidies and Cancer.Cytogenetics and molecular genetics of human solid tumours.Localization and expression of the human estrogen receptor beta gene in uterine leiomyomata.Leiomyoma of uterus in a patient with ring chromosome 12: case presentation and literature review.Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.Cytogenetic findings in liposarcoma correlate with histopathologic subtypes.Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata.Congenital mesoblastic nephroma: cytogenetic comparison to leiomyoma.Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.An immunohistochemical study of the mesenchymal and epithelial components of pulmonary chondromatous hamartomas.Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas.Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
P2860
Q24815132-FBCBD375-4C94-4E12-910B-FF919775DE20Q31111299-4B7B6716-E36E-42A0-88BA-D43DEEE72516Q34086295-F103A995-3C96-41BE-8976-58AD821EA274Q34125175-B971FB81-18CA-48C7-A145-1A9CD1ADE1B7Q34200520-6478666F-E43E-4A4E-8B99-0F6CFFEB0A19Q34200667-54BDE362-BD04-4971-9AC8-57BFF1AD2ABCQ34362689-32481A6B-54DE-4E67-B9BA-C57388CA8D39Q34651510-212C7732-25C8-46D4-B6BB-AFB2AFCC29C3Q34847625-B6D32E3D-13F7-4518-B620-D417D8ECDE02Q35753468-6FCF7F4C-3107-4D4C-9406-C9DAEFB60EA7Q35763527-85E1E48F-A1F9-4B5A-8DA9-3C7C8EBD5AD3Q35832616-937857D8-818E-4C73-A24D-BCE42DFF1A87Q35834120-911E5C21-BC4E-40F3-8CA0-B6C24FA163E5Q35909440-0AC7F778-E50A-4776-9D9E-3573F8EB2C12Q35944399-2A4148A6-6136-4B86-8908-03BAD933DE3FQ35977061-05099EAB-C9D0-46C1-98F5-2C94F1266587Q36579870-6A55BDDA-DF7F-4546-8DB5-B57F67834734Q36598114-895BDECD-8A9B-464A-A4D7-36BF76E8A1C5Q36828363-C98ADC6B-1FB5-48F8-A7A0-C38A6C449794Q36974414-9E7BDBB4-29CE-459F-A6AF-578252BFDE83Q37423366-7214F651-57C6-4FF4-9F0A-F26474A798CBQ37497504-8956DD8A-7F40-46B5-AF6C-83AD202B145DQ38430779-7AAAADDE-4222-4B0F-8389-A93D036C6D5CQ38499610-8E3398A0-AAF1-49CC-80A1-BEF87A9EB937Q40418811-73B7636F-3DBB-49E5-8086-A1BC616FA398Q40834742-686CCC71-240C-4FE6-A417-F15F208D4ECEQ41048910-4EF8349D-F629-4C94-893A-6A36E6C855F5Q42341131-A5486A2A-29D7-4A44-B295-05432F4103F6Q44846709-5D1870A5-645A-44ED-A610-0E5031C51B92Q45092697-DAB2DB1E-2293-4032-9341-54C898693D73Q46342485-2CBDBA5A-D6CA-490A-BBDF-7E14C9BA1FF8Q47850947-629B287F-A5BA-4179-858C-C666E7F98CB7Q47862658-AAE56D88-52B5-4529-AF81-F0E9298BF443Q52172564-AFA4CDCC-76C7-494C-8B2F-855523EFE935Q52522009-6E6625A6-7255-4A04-9586-38D4F74D50E6Q52884225-E5EA91B5-936C-4DD7-8F09-9735ED16807CQ53441049-1F241DD1-1D13-4C52-80C0-A82F315C5AAD
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Uterine leiomyoma cytogenetics.
@en
type
label
Uterine leiomyoma cytogenetics.
@en
prefLabel
Uterine leiomyoma cytogenetics.
@en
P356
P1476
Uterine leiomyoma cytogenetics.
@en
P356
10.1002/GCC.2870020103
P577
1990-05-01T00:00:00Z